| Code | Description | Claims | Beneficiaries | Total Paid |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
14,295 |
12,891 |
$1.54M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
5,084 |
4,362 |
$627K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
1,153 |
813 |
$352K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
7,019 |
5,679 |
$260K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
2,541 |
726 |
$167K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
1,457 |
1,272 |
$165K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
602 |
486 |
$143K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
912 |
853 |
$95K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
507 |
487 |
$95K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
568 |
430 |
$88K |
| 70450 |
Computed tomography, head or brain; without contrast material |
353 |
311 |
$81K |
| 80053 |
Comprehensive metabolic panel |
5,090 |
4,463 |
$64K |
| 84443 |
Thyroid stimulating hormone (TSH) |
2,473 |
2,310 |
$56K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
425 |
284 |
$54K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
467 |
375 |
$49K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
944 |
888 |
$45K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
789 |
707 |
$44K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
442 |
360 |
$40K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
808 |
734 |
$38K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
10,101 |
8,566 |
$35K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
987 |
917 |
$32K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
674 |
616 |
$27K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
93 |
82 |
$27K |
| 80061 |
Lipid panel |
1,808 |
1,696 |
$24K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
872 |
262 |
$22K |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
1,304 |
1,251 |
$22K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
2,118 |
1,734 |
$22K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
1,632 |
1,531 |
$21K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
430 |
407 |
$17K |
| 87428 |
|
612 |
505 |
$16K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
671 |
615 |
$15K |
| 71046 |
Radiologic examination, chest; 2 views |
515 |
453 |
$14K |
| 36415 |
Collection of venous blood by venipuncture |
10,532 |
8,759 |
$14K |
| G0378 |
Hospital observation service, per hour |
140 |
55 |
$13K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
538 |
499 |
$13K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,382 |
879 |
$12K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
81 |
37 |
$11K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
1,249 |
1,061 |
$11K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
2,597 |
2,048 |
$10K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
28 |
26 |
$8K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
271 |
260 |
$7K |
| 84439 |
|
374 |
336 |
$7K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
2,208 |
1,787 |
$6K |
| 87806 |
|
179 |
159 |
$6K |
| G0472 |
Hepatitis c antibody screening, for individual at high risk and other covered indication(s) |
187 |
169 |
$5K |
| 83540 |
|
505 |
470 |
$5K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
14 |
13 |
$5K |
| 71045 |
Radiologic examination, chest; single view |
1,175 |
989 |
$4K |
| 85652 |
|
1,146 |
1,090 |
$4K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
16 |
12 |
$4K |
| 82728 |
|
160 |
154 |
$3K |
| 87430 |
|
457 |
405 |
$3K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
1,769 |
1,442 |
$3K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
181 |
143 |
$3K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
1,766 |
1,347 |
$2K |
| 82570 |
|
238 |
206 |
$2K |
| 81001 |
|
1,600 |
1,338 |
$2K |
| 80076 |
|
438 |
344 |
$2K |
| 85027 |
|
320 |
261 |
$2K |
| 87077 |
|
245 |
201 |
$2K |
| 83550 |
|
218 |
206 |
$2K |
| 86850 |
|
112 |
105 |
$2K |
| 87186 |
|
308 |
262 |
$2K |
| 82607 |
|
80 |
74 |
$2K |
| 73630 |
|
81 |
70 |
$2K |
| 86140 |
|
236 |
202 |
$2K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
31 |
28 |
$1K |
| 83735 |
|
679 |
523 |
$1K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
19 |
13 |
$1K |
| 59025 |
Fetal non-stress test |
19 |
13 |
$1K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
187 |
155 |
$1K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
905 |
621 |
$1K |
| 97162 |
|
15 |
15 |
$1K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
35 |
28 |
$1K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
41 |
40 |
$981.12 |
| 81003 |
|
436 |
379 |
$948.91 |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
15 |
15 |
$930.02 |
| 96376 |
|
194 |
124 |
$800.53 |
| 86900 |
|
150 |
133 |
$798.89 |
| 86901 |
|
150 |
133 |
$781.19 |
| 87070 |
|
69 |
67 |
$736.07 |
| 82962 |
|
568 |
371 |
$561.44 |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
13 |
13 |
$545.04 |
| 84153 |
|
29 |
29 |
$534.85 |
| 87071 |
|
51 |
50 |
$485.57 |
| 86762 |
|
28 |
27 |
$466.10 |
| 84484 |
|
1,115 |
814 |
$441.28 |
| 83690 |
|
940 |
721 |
$382.72 |
| J3490 |
Unclassified drugs |
155 |
88 |
$370.04 |
| 80320 |
|
55 |
38 |
$370.00 |
| 73130 |
|
13 |
12 |
$327.20 |
| 82043 |
|
45 |
39 |
$310.78 |
| 85610 |
|
158 |
136 |
$303.26 |
| 73610 |
|
13 |
12 |
$269.82 |
| 84702 |
|
18 |
12 |
$196.02 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
985 |
808 |
$194.83 |
| 83880 |
|
96 |
84 |
$116.76 |
| 81025 |
|
616 |
476 |
$109.53 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
944 |
677 |
$100.03 |
| 90715 |
|
14 |
12 |
$87.10 |
| 87205 |
|
16 |
14 |
$76.43 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
578 |
432 |
$50.67 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
1,135 |
824 |
$46.17 |
| 85730 |
|
34 |
28 |
$42.82 |
| 83605 |
|
127 |
104 |
$32.19 |
| 82150 |
|
125 |
118 |
$30.23 |
| 84703 |
|
52 |
41 |
$27.67 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
14 |
12 |
$24.86 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
157 |
129 |
$18.92 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
1,487 |
1,091 |
$14.62 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
16 |
13 |
$13.18 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
29 |
27 |
$3.60 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
234 |
168 |
$3.39 |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
35 |
25 |
$3.20 |
| J2704 |
Injection, propofol, 10 mg |
516 |
358 |
$2.16 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
49 |
44 |
$0.33 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
15 |
13 |
$0.00 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
37 |
34 |
$0.00 |
| 4004F |
|
13 |
13 |
$0.00 |
| J1171 |
Injection, hydromorphone, 0.1 mg |
13 |
12 |
$0.00 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
139 |
121 |
$0.00 |
| 82803 |
|
33 |
28 |
$0.00 |
| 85379 |
|
18 |
14 |
$0.00 |